| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039271369 |
| P356 | DOI | 10.1186/1477-7819-11-74 |
| P8608 | Fatcat ID | release_l4ebdoljmfbmrnpcrsmtffr3oe |
| P932 | PMC publication ID | 3620941 |
| P698 | PubMed publication ID | 23518204 |
| P5875 | ResearchGate publication ID | 236070178 |
| P2093 | author name string | Yu Li | |
| Gang Zhao | |||
| Li Ren | |||
| Hong-Yi Zhang | |||
| Dong-Qing Wen | |||
| Ya-Lin Kong | |||
| Zi-ming Huang | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Activation of Arp2/3 complex-mediated actin polymerization by cortactin | Q24290885 | ||
| The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites | Q24605485 | ||
| Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex | Q24674103 | ||
| Cortactin: coupling membrane dynamics to cortical actin assembly | Q28199365 | ||
| Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation | Q28206691 | ||
| Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas | Q28278058 | ||
| The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells | Q28283364 | ||
| Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia | Q28300785 | ||
| Cortactin regulates cell migration through activation of N-WASP | Q28594449 | ||
| Hepatocellular carcinoma | Q29616359 | ||
| Identification and characterization of a novel cytoskeleton-associated pp60src substrate | Q30195583 | ||
| Chromosome 11Q13 amplification in head and neck squamous cell carcinoma | Q30466685 | ||
| A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. | Q34579605 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Cyclin D1, EMS1 and 11q13 amplification in breast cancer | Q35130688 | ||
| Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index | Q35791700 | ||
| Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status | Q36494146 | ||
| Regulation of the actin cytoskeleton in cancer cell migration and invasion | Q36574131 | ||
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer | Q36678853 | ||
| A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma | Q37336698 | ||
| Prognostic and diagnostic value of des-gamma-carboxy prothrombin in liver cancer | Q37804705 | ||
| Hepatocellualar carcinoma serum markers | Q38030776 | ||
| A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma | Q39905453 | ||
| Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells | Q40284719 | ||
| Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function | Q40304153 | ||
| Cortactin promotes cell motility by enhancing lamellipodial persistence | Q40392234 | ||
| Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor | Q40434399 | ||
| Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. | Q40508457 | ||
| Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro | Q42827786 | ||
| Postoperative Recurrence of Hepatocellular Carcinoma | Q43969585 | ||
| Interaction of cortactin and N-WASp with Arp2/3 complex | Q44101124 | ||
| The novel dominant mutation Dspd leads to a severe spermiogenesis defect in mice | Q47296617 | ||
| Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer | Q59616875 | ||
| Markers for assessment of nodal metastasis in laryngeal carcinoma | Q73245302 | ||
| Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma | Q73727350 | ||
| EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck | Q74216160 | ||
| EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival | Q77332015 | ||
| Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma | Q81926132 | ||
| Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma | Q84140338 | ||
| [Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China, 2004 - 2005] | Q84589228 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 74 | |
| P577 | publication date | 2013-03-21 | |
| P1433 | published in | World Journal of Surgical Oncology | Q14520241 |
| P1476 | title | Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma | |
| P478 | volume | 11 |
| Q35897689 | Association between genetic polymorphisms in cortactin and susceptibility to gastric cancer |
| Q37660692 | Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells |
| Q37702124 | Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway |
| Q42087031 | Downregulation of ADAM10 expression inhibits metastasis and invasiveness of human hepatocellular carcinoma HepG2 cells |
| Q53453636 | Expression and significance of cortactin and HDAC6 in human prostatic foamy gland carcinoma. |
| Q35097632 | Genome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer |
| Q55286596 | Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma. |
| Q39174153 | Overexpression of Abl2 predicts poor prognosis in hepatocellular carcinomas and is associated with cancer cell migration and invasion |
| Q35932609 | Systems biology approach to studying proliferation-dependent prognostic subnetworks in breast cancer. |
Search more.